APO Research
Talk to an analyst

APO RESEARCH · REPORT

10-Valent Pneumococcal Polysaccharide Vaccine

10-Valent Pneumococcal Polysaccharide Vaccine is a vaccine product category defined by its pneumococcal antigen composition and formulation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antigen composition, conjugation status, presentation and labelled indications distinguish supplied vaccines. Products with different compositions are not interchangeable solely because a headline count is similar.

The commercial boundary

The selected edition describes a market scope. Product approvals, labelled use and clinical acceptance require their own evidence; neither report segmentation nor an illustrative image establishes medical suitability.

Which antigen composition and formulation define the vaccine?

Antigen composition, conjugation status, presentation and labelled indications distinguish supplied vaccines. Products with different compositions are not interchangeable solely because a headline count is similar.

Selected research

Industry Research

10-Valent Pneumococcal Polysaccharide Vaccine Industry Research Report 2026

22 December 2025107 pages

Choose your research edition.

Industry Research10-Valent Pneumococcal Polysaccharide Vaccine Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal 10-Valent Pneumococcal Polysaccharide Vaccine Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal 10-Valent Pneumococcal Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 10-Valent Pneumococcal Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal 10-Valent Pneumococcal Polysaccharide Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global 10-Valent Pneumococcal Polysaccharide Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for 10-Valent Pneumococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for 10-Valent Pneumococcal Polysaccharide Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for 10-Valent Pneumococcal Polysaccharide Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of 10-Valent Pneumococcal Polysaccharide Vaccine include GSK. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global 10-Valent Pneumococcal Polysaccharide Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

10-Valent Pneumococcal Polysaccharide Vaccine Market by Company

GSK

10-Valent Pneumococcal Polysaccharide Vaccine Segment by Type

Single Dose Vial

Pre-filled Syringe

10-Valent Pneumococcal Polysaccharide Vaccine Segment by Application

Hospital

Clinic

10-Valent Pneumococcal Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 10-Valent Pneumococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 10-Valent Pneumococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 10-Valent Pneumococcal Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of 10-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of 10-Valent Pneumococcal Polysaccharide Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of 10-Valent Pneumococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global 10-Valent Pneumococcal Polysaccharide Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (k units) of Manufacturers (2021-2026) Table 7. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market 10-Valent Pneumococcal Polysaccharide Vaccine Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global 10-Valent Pneumococcal Polysaccharide Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of 10-Valent Pneumococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of 10-Valent Pneumococcal Polysaccharide Vaccine, Product Type & Application Table 14. Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global 10-Valent Pneumococcal Polysaccharide Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. GSK Company Information Table 19. GSK Business Overview Table 20. GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. GSK 10-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio Table 22. GSK Recent Developments Table 23. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 24. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (k units) Table 25. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2021-2026) Table 26. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2027-2032) & (k units) Table 27. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2027-2032) Table 28. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 29. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2026) Table 30. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 31. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2027-2032) Table 32. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 33. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 34. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 35. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 36. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 37. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 39. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 40. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 41. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 42. Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 44. Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 45. Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 46. Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 47. South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 48. South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 49. South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 50. South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 51. South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 52. Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 54. Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 55. Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 56. Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 57. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 58. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (k units) Table 59. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026) Table 60. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2027-2032) Table 61. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 62. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 63. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2026) Table 64. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2027-2032) Table 65. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2021-2026) & (US$/unit) Table 66. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2027-2032) & (US$/unit) Table 67. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 68. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (k units) Table 69. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2026) Table 70. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2027-2032) Table 71. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 72. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 73. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2026) Table 74. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2027-2032) Table 75. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2021-2026) & (US$/unit) Table 76. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2027-2032) & (US$/unit) Table 77. Key Raw Materials Table 78. Raw Materials Key Suppliers Table 79. 10-Valent Pneumococcal Polysaccharide Vaccine Distributors List Table 80. 10-Valent Pneumococcal Polysaccharide Vaccine Customers List Table 81. 10-Valent Pneumococcal Polysaccharide Vaccine Industry Trends Table 82. 10-Valent Pneumococcal Polysaccharide Vaccine Industry Drivers Table 83. 10-Valent Pneumococcal Polysaccharide Vaccine Industry Restraints Table 84. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. 10-Valent Pneumococcal Polysaccharide Vaccine Product Image Figure 5. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (2021-2032) & (k units) Figure 8. Global 10-Valent Pneumococcal Polysaccharide Vaccine Average Price (US$/unit) & (2021-2032) Figure 9. Single Dose Vial Product Image Figure 10. Pre-filled Syringe Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of 10-Valent Pneumococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 10-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region in 2025 Figure 19. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region in 2025 Figure 20. North America 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country in 2025 Figure 21. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 22. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021-2032) Figure 23. United States 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country in 2025 Figure 27. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 28. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021-2032) Figure 29. Germany 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country in 2025 Figure 40. Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021-2032) Figure 42. China 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country in 2025 Figure 51. South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 52. South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021-2032) Figure 53. Brazil 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country in 2025 Figure 57. Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2021-2032) Figure 59. Egypt 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2032) Figure 65. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2032) Figure 66. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price (US$/unit) by Type (2021-2032) Figure 67. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2032) Figure 68. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2032) Figure 69. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price (US$/unit) by Application (2021-2032) Figure 70. 10-Valent Pneumococcal Polysaccharide Vaccine Value Chain Figure 71. 10-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. 10-Valent Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Single Dose Vial
  • Pre-filled Syringe
Applications
  • Hospital
  • Clinic
Companies covered
  • GSK

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size (2021-2032)
  4. 2.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (2021-2032)
  5. 2.2.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Average Price (2021-2032)
  6. 2.3 10-Valent Pneumococcal Polysaccharide Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Single Dose Vial
  9. 2.3.3 Pre-filled Syringe
  10. 2.4 10-Valent Pneumococcal Polysaccharide Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global 10-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global 10-Valent Pneumococcal Polysaccharide Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of 10-Valent Pneumococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of 10-Valent Pneumococcal Polysaccharide Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of 10-Valent Pneumococcal Polysaccharide Vaccine, Established Date
  9. 3.9 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 GSK
  2. 4.1.1 GSK Company Information
  3. 4.1.2 GSK Business Overview
  4. 4.1.3 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
  6. 4.1.5 GSK Recent Developments
5 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Scenario by Region
  1. 5.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2027-2032
  5. 5.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America 10-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
  16. 5.5.1 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2032)
  18. 5.5.3 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America 10-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
  41. 5.7.1 South America 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2032)
  43. 5.7.3 South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 10-Valent Pneumococcal Polysaccharide Vaccine Value Chain Analysis
  2. 8.1.1 10-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 10-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process
  5. 8.2 10-Valent Pneumococcal Polysaccharide Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 10-Valent Pneumococcal Polysaccharide Vaccine Distributors
  8. 8.2.3 10-Valent Pneumococcal Polysaccharide Vaccine Customers
9 Global 10-Valent Pneumococcal Polysaccharide Vaccine Analyzing Market Dynamics
  1. 9.1 10-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
  2. 9.2 10-Valent Pneumococcal Polysaccharide Vaccine Industry Drivers
  3. 9.3 10-Valent Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 9.4 10-Valent Pneumococcal Polysaccharide Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst